Detalhe da pesquisa
1.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
N Engl J Med
; 389(26): 2436-2445, 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921461
2.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Lancet
; 401(10388): 1584-1594, 2023 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015244
3.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Lancet
; 402(10417): 2077-2090, 2023 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931634
4.
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
Am J Kidney Dis
; 83(1): 37-46, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657635
5.
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases.
Am J Kidney Dis
; 82(2): 121-175, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341661
6.
COL4A gene variants are common in children with hematuria and a family history of kidney disease.
Pediatr Nephrol
; 38(11): 3625-3633, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204491
7.
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. Reply.
N Engl J Med
; 390(12): 1154-1155, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507769
8.
Multisite Retrospective Review of Outcomes in Renal Replacement Therapy for Neonates with Inborn Errors of Metabolism.
J Pediatr
; 246: 116-122.e1, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358588
9.
Utility of the 2018 revised ISN/RPS thresholds for glomerular crescents in childhood-onset lupus nephritis: a Pediatric Nephrology Research Consortium study.
Pediatr Nephrol
; 37(12): 3139-3145, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347402
10.
Cardiovascular disease in children with chronic kidney disease.
Curr Opin Nephrol Hypertens
; 30(2): 231-236, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464005
11.
Liver transplant as a curative treatment in a pediatric patient with classic homocystinuria: A case report.
Am J Med Genet A
; 185(4): 1247-1250, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33443292
12.
Angiotensin-converting enzyme inhibitors in patients with Alport syndrome: can all patients benefit?
Kidney Int
; 98(6): 1400-1402, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33276866
13.
Long-term ACE inhibition in Alport syndrome: are the benefits worth the risks?
Kidney Int
; 97(6): 1104-1106, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32444091
14.
Role of direct oral anticoagulants in patients with kidney disease.
Kidney Int
; 97(4): 664-675, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107019
15.
Clinical trial recommendations for potential Alport syndrome therapies.
Kidney Int
; 97(6): 1109-1116, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32386680
16.
Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi Survey.
Am J Kidney Dis
; 76(4): 533-545, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654889
17.
The importance of clinician, patient and researcher collaborations in Alport syndrome.
Pediatr Nephrol
; 35(5): 733-742, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31044288
18.
A dual efficacy-implementation trial of a novel mobile application for childhood nephrotic syndrome management: the UrApp for childhood nephrotic syndrome management pilot study protocol (UrApp pilot study).
BMC Nephrol
; 21(1): 125, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32272901
19.
Segmental infantile hemangioma and concomitant hypertension in three African American neonates.
Pediatr Dermatol
; 37(3): 524-526, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32053242
20.
Kidney transplant outcomes associated with the use of increased risk donors in children.
Am J Transplant
; 19(6): 1684-1692, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30582274